Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.
复制标题
急性心肌梗死后β-肾上腺素能拮抗剂的短期和长期影响。
DOI:
10.1016/s0002-9149(84)80307-0
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
Buja,LM
中科院分区:
文献类型:
--
作者:
Willerson,JT;Buja,LM
After coronary arterial occlusion, catecholamines are released from storage depots in the left ventricle and injured myocardial cells are exposed to relatively high concentrations of catecholamines during the evolutionary period in which cell injury is becoming progressively more severe. In addition, in experimental animal models, there is a substantial increase in β-adrenergic receptor density without any alteration in affinity within 1 hour of permanent coronary arterial occlusion. Recent data suggest that α-adrenergic receptor density increases within 30 to 60 minutes after coronary arterial occlusion in experimental animal models. The administration of catecholamines during the early phases of evolving myocardial injury can result in heightened adrenergic biochemical responses in severely injured compared with normally perfused tissue in the hearts of experimental animals. Thus, there is adequate rationale for anticipating that β-adrenergic antagonists would protect ischemic myocardium and potentially reduce the incidence of life-threatening arrhythmias in individuals with evolving acute myocardial infarction (AMI). Studies in animal models demonstrate that the administration of β-adrenergic antagonists in the first few minutes after coronary artery occlusion may reduce the ultimate extent of myocardial necrosis. Clinical data from several different trials in which β-adrenergic antagonists were administered to (1) protect ischemic myocardium and preserve ventricular function and (2) reduce the severity of serious ventricular arrhythmias in patients with AMI are reviewed. The effects of longer-term administration of β-adrenergic antagonists in patients after AMI in prolonging life and reducing risk of reinfarction are presented.
登录
查看更多内容
影响因子:
5
作者:
PODZUWEIT, T;DALBY, AJ;OPIE, LH
通讯作者:
OPIE, LH
影响因子:
--
作者:
G. Ahumada;R. Karlsberg;A. Jaffe;H. Ambos;And BURTON E. SOBEL;R. Roberts
通讯作者:
R. Roberts
影响因子:
20.1
作者:
A. Mukherjee;L. Bush;K. McCoy;R. Duke;H. Hagler;L. Buja;J. Willerson
通讯作者:
J. Willerson
影响因子:
20.1
作者:
J. Willerson;J. Watson;I. Hutton;G. Templeton;D. Fixler
通讯作者:
D. Fixler
影响因子:
15.9
作者:
A. Mark;F. Abboud;P. Schmid;D. Heistad;H. Mayer
通讯作者:
H. Mayer